A double-blind, placebo-controlled trial of pioglitazone in the treatment of non-alcoholic steatohepatitis (NASH)

被引：0
|
作者：
Harrison, S
Belfort, R
Brown, K
Darland, C
Finch, J
Fincke, C
Havranek, R
Hardies, J
Dwivedi, S
Berria, R
Tio, FM
Schenker, S
Cusi, K
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A681 / A681
页数：1
相关论文
共 50 条
  • [41] Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial (vol 14, e0221683, 2019)
    Navarro, Victor J.
    Belle, Steven H.
    D'Amato, Massimo
    Afdhal, Nezam
    Brunt, Elizabeth M.
    Fried, Michael W.
    Reddy, K. Rajender
    Wahed, Abdus S.
    Harrison, Stephen
    PLOS ONE, 2019, 14 (10):
  • [42] DISEASE PROGRESSION IN TAIWANESE NON-ALCOHOLIC STEATOHEPATITIS PATIENTS: SUBGROUP ANALYSIS OF THE PLACEBO PATIENTS IN A DOUBLE-BLIND RANDOMIZED TRIAL
    Yeh, Ming-Lun
    Huang, Jee-Fu
    Huang, Chung-Feng
    Dai, Chia-Yen
    Yu, Ming-Lung
    Chuang, Wan Long
    HEPATOLOGY, 2023, 78 : S950 - S951
  • [43] A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis
    Rinella, Mary E.
    Lieu, Hsiao D.
    Kowdley, Kris V.
    Goodman, Zachary D.
    Alkhouri, Naim
    Lawitz, Eric
    Ratziu, Vlad
    Abdelmalek, Manal F.
    Wong, Vincent Wai-Sun
    Younes, Ziad H.
    Sheikh, Aasim M.
    Brannan, Donald
    Freilich, Bradley
    Membreno, Fernando
    Sinclair, Marie
    Melchor-Khan, Liza
    Sanyal, Arun J.
    Ling, Lei
    Harrison, Stephen A.
    HEPATOLOGY, 2024, 79 (03) : 674 - 689
  • [44] Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial
    Traussnigg, Stefan
    Schattenberg, Jorn M.
    Demir, Munevver
    Wiegand, Johannes
    Geier, Andreas
    Teuber, Gerfinde
    Hofmann, Wolf Peter
    Kremer, Andreas E.
    Spreda, Frank
    Kluwe, Johannes
    Petersen, Jorg
    Boettler, Tobias
    Rainer, Florian
    Halilbasic, Emina
    Greinwald, Roland
    Prols, Markus
    Manns, Michael P.
    Fickert, Peter
    Trauner, Michael
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (10): : 781 - 793
  • [45] Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease - A double-blind, placebo-controlled trial
    Bode, C
    Schafer, C
    Fukui, H
    Bode, JC
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1997, 21 (08) : 1367 - 1373
  • [46] A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
    Belfort, Renata
    Harrison, Stephen A.
    Brown, Kenneth
    Darland, Celia
    Finch, Joan
    Hardies, Jean
    Balas, Bogdan
    Gastaldelli, Amalia
    Tio, Fermin
    Pulcini, Joseph
    Berria, Rachele
    Ma, Jennie Z.
    Dwivedi, Sunil
    Havranek, Russell
    Fincke, Chris
    DeFronzo, Ralph
    Bannayan, George A.
    Schenker, Steven
    Cusi, Kenneth
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22): : 2297 - 2307
  • [47] TREATMENT-RELATED SUICIDALITY - A PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL
    TOLLEFSON, GD
    CLINICAL RESEARCH, 1991, 39 (03): : A768 - A768
  • [48] DEXAMETHASONE FOR THE TREATMENT OF DEPRESSION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    ARANA, GW
    SANTOS, AB
    LARAIA, MT
    MCLEODBRYANT, S
    BEALE, MD
    RAMES, LJ
    ROBERTS, JM
    DIAS, JK
    MOLLOY, M
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (02): : 265 - 267
  • [49] A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus - Reply
    Roberson, J
    Westerberg, B
    Stach, B
    AMERICAN JOURNAL OF OTOLOGY, 1997, 18 (02): : 268 - 269
  • [50] Sodium oxybate for the treatment of fibromyalgia: A double-blind, placebo-controlled trial
    Mannelli, Paolo
    Patkar, Ashwin
    Kuhn, Cynthia
    Perera, Philip
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S260 - S260
12345